Background macular Shape Background macular Shape Background macular Shape
Grants > Bioengineering Studies of Transport Across Bruch's Membrane Updated On: Jan. 21, 2025
Macular Degeneration Research Grant

Bioengineering Studies of Transport Across Bruch's Membrane

Principal Investigator

Mark Johnson, PhD

Northwestern University-Chicago Campus

Chicago, IL, USA

About the Research Project

Program

Macular Degeneration Research

Award Type

Standard

Award Amount

$100,000

Active Dates

April 01, 2003 - March 31, 2006

Grant ID

M2003044

Co-Principal Investigator(s)

Christine Curcio, PhD, University of Alabama at Birmingham

Summary

Bruch’s membrane is a thin connective tissue layer that lies between the eye’s choriocapillaris (minute blood vessels of the choroid layer) and the retinal pigment epithelium. Since the transport of nutrients to the retina and the disposal of waste products must pass through Bruch’s membrane, the obstruction of transport through this tissue can have serious physiological consequences. It is known that the early stages of age-related macular degeneration (AMD) are characterized by minor to moderate vision loss that is associated with debris accumulation, particularly the accumulation of lipids. Dr. Johnson and his colleagues are exploring the hypothesis that this accumulation of debris impairs the transport capacity of Bruch’s membrane, leading to a progressive worsening of the condition. Because the only known risk factor for the early stages of macular degeneration is advanced age, it is important to understand how age-related changes in Bruch’s membrane may predispose some individuals to lesion development. Dr. Johnson is using a bioengineering technique called quick freeze/deep etch to examine how the transport capacity of Bruch’s membrane changes with age. The results of this study are expected to provide a firm quantitative basis for understanding the transport properties in Bruch’s membrane of eyes that have macular degeneration, leading to the development of better treatments or even a means of preventing AMD. This project is a continuation of a Macular Degeneration Research study initiated in 2001.